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This paper describes the cloning and sequence analysis
of the cDNAs encoding the canine homologues of
interleukin-3 (IL-3) and interleukin-6 (IL-6). The coding
sequences for canine IL-3 and IL-6 were obtained by
using the reverse transcription polymerase chain reaction
(RT-PCR) with RNA harvested from canine peripheral
blood mononuclear cells (PBMCs). Canine IL-3 cDNA
includes a single open reading frame of 432 nucleotides,
which encodes a 143 amino acid polypeptide and has 44.7,
42.4, 37 and 23.7% homology with the cow, sheep, human
and rat IL-3 sequences, respectively. Canine IL-6 cDNA
(GenBank accession number; AF275796) encodes a
putative 20-amino acid signal peptide followed by a 187-
amino acid mature protein. The predicted amino acid
sequence of canine IL-6 shares 60.4, 77.2, 71.0, 55.8 and
42.0% sequence identity with those of human, feline,
porcine, sheep and rat IL-6, respectively. 
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Introduction
Interleukin-3 (IL-3) is a glycoprotein which has a broad
spectrum colony stimulating effect. IL-3 acts on primitive
pluripotent stem cells and progenitor cells of every lineage,
except for those committed to the T-lymphoid and B-
lymphoid lineages. IL-3 is also called multi-colony
stimulating factor (CSF), mast-cell growth factor or stem
cell activating factor and has many other names [15]. Thus,
IL-3 can stimulate the generation and differentiation of
macrophages, neutrophils, eosinophils, basophils, mast
cells, megakaryocytes and erythroid cells [24].
Furthermore, IL-3 synergizes with other cytokines to
support the complete and amplified development of several
hematopoietic lineages, including those of eosinophils and
macrophages [16,20]. Activated T-cells are mainly
responsible for secreted IL-3 [9,22,23] though small
amount is produced by activated natural killer (NK) cells,
mast cells and eosinophils. IL-3 is a important growth
factor that ligand the immune system and homeostasis in
non-immune tissues. Genes coding for mouse, rat, human,
gibbon, rhesus monkey and sheep IL-3 have been cloned
and the recombinant protein expressed [2,4,5,7,14,28]. IL-
3 is a relatevely small protein, with a polypeptide chain
ranging from 140 to 166 amino acids.
IL-6 also has been called by a variety of names, such as
interfeon-b2 (IFN-b2), T-cell replacing factor (TRF)-like
factor, B-cell differentiation factor (BCDF), BCDF2, 26-
kDa protein, B-cell stimulatory factor-2 (BSF-2),
hybridoma-plasmacytoma growth factor (HPGF or IL-
HP1), hepatocyte stimulating factor (HSF) and monocyte-
granulocyte inducer type 2 (MGI-2). However, molecular
cloning of IFN-b2, 26-kDa protein and BSF-2 revealed that
all these molecules are identical. IL-6 is a multifunctional
cytokine, which is produced by both lymphoid and non-
lymphoid cells and regulates immune responses [26],
acute-phase reactions [8,21] and haematopoiesis [10]. IL-6
also has roles as an autocrine growth stimulator in a
number of tumors, most notably plasmacytomas and
myelomas [17,25] and for some normal cell types. It also
has a number of functions in the endocrine and nervous
systems. Over-expression of IL-6 is known to be an
important feature of the pathogenesis of a number of
inflammatory diseases, such as rheumatoid arthritis,
glomerular nephritis and psoriasis.
We cloned the full coding region of canine IL-3 and IL-6
from peripheral blood using PCR (polymerase chain
reaction) assay and performed nucleotide sequence
analysis to allow comparison to be made with other
species.
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Materials and Methods
Part A. Canine IL-3 cDNA amplification
Preparation of blood cells
A normal healthy adult dog served as a blood donor.
Peripheral blood mononuclear cells (PBMCs) were
seperated from approximately 30 ml of venous blood
supplemented with 3.5 ml citrate phosphate dextrose acid
(CPDA) as an anti-coagulant. PBMCs were separated by
Ficoll Paque (Pharmacia Biotech, Uppsala, Sweden)
gradient centrifugation at 1800 rpm, 20 min [3]. Cell
viabiliy was determined by the trypan blue dye exclusion
method. Cells were washed twice with phosphate-buffered
saline (PBS) and plated to a concentration of 1 ´ 10
6 cells
per ml in RPMI 1640 (GIBCO, Grand Island, USA)
supplemented with 10% fetal calf serum (FCS) and 50 mg/
ml of gentamicin. In order to stimulate the T-lymphocytes,
each of the following reagents-1) 10 mg/ml concanavaline
A (ConA), 2) 10 mg/ml lipopolysaccharide (LPS) or 3) 10
ß¹/ml ConA plus 10 ng/ml phorbol 12, 13-myristate
acetate (PMA)-was added to the medium. These T-
lymphocytes were then cultured for 2 h, 4 h and 7 h at
37
oC in a humidified incubator with a 5% CO2 atmosphere.
After cultivation, the canine cells were collected by
centrifugation and then quickly frozen in liquid nitrogen.
Isolation of RNA and the preparation of cDNA
Total RNA was isolated from lymphocytes stimulated
with ConA, LPS or ConA plus PMA using TRIzol (Gibco,
NY, USA). The RNA concentration was approximately
0.25 mg/ml and 2 mg of RNA was used in the synthesis of
first strand cDNA using moloney murine leukemia virus
reverse transcriptase (M-Mulv RT) and oligo(dT)18 primer,
according to the manufacturer’s instructions.
Polymerase chain reaction
The following primer pairs were used for the PCR
reaction. The foward BamHIcaIL3-F primer (5’-CCG
GGA TCC AGC AGC TTC CCC ATC CTG CAC-3’ nt;
52-71) and the reverse HindIIIcaIL3-R primer (5’-CCG
AAG CTT AGG CCC CAT GAT GAG AAG GCC-3’ nt;
505-525) were synthesized based on the canine IL-3
sequence (GeneBank accession number; AF250764) and
BamHI and HindIII restriction sites were added to the 5’-
ending region of these two primers for vector ligation.
Using these primers, a 480 bp fragment, including the
whole coding sequence of canine IL-3, was expected to be
amplified. The PCR amplification was performed for 30
cycles at 94
oC for 1 min, 55
oC for 1 min, 72
oC for 1 min
with an additional extension step at 72
oC for 10 min.
Part B. Canine IL-6 cDNA amplification
Preparation of canine blood cell
A normal healthy adult dog served as a blood donor.
PBMCs were separated from approximately 10 ml of
venous blood supplemented with 1.14 ml of CPDA as anti-
coagulant. Ficoll-Paque gradient centrifugation was then
performed. PBMCs were washed twice with PBS and
adjusted to 1 ´ 10
6 viable cells per ml in RPMI 1640
medium supplemented with 10% FCS and 50 mg/ml of
gentamicin, and stimulated with 5 mg/ml of LPS at 37
oC in
a humidified incubator with 5% CO2 atmosphere. After
cultivating for 4 hours, the canine PBMCs were collected
by centrifugation and then quickly frozen in liquid
nitrogen. Total RNA extraction and cDNA preparation was
performed as described above.
Polymerase chain reaction
Primer pairs were prepared based on the sequence of
canine IL-6 mRNA (GenBank accession number;
CFU12234). The primer sequences used for amplifying of
canine IL-6 were 5’-ATG AAC TCC CTC TCC ACA AG-
3’ (il6S; nt. 58-77) and 5’-CTA CAT TAT CCG AAC AGC
CC-3’ (il6R; nt. 662-681). Using these primers, we
expected about 620 bp fragments, including the whole
coding sequence of canine IL-6, to be amplified. The
cDNA was amplified by PCR in a final volume of 50 ml,
using the primer pairs (1.0 uM each), Taq polymerase (1.5
units), and the reagents recommended by the manufacturer
(Takara, Otsu, Japan). Samples were subjected to an initial
denaturation at 94
oC for 5 min followed by 30 cycles of
amplification, each cycle consisted of denaturation at 94
oC
for 1 min, annealing at 55
oC for 1 min and extension at
72
oC for 1 min with an additional final 10-min incubation
at 72
oC to complete all extensions.
Cloning and nucleotide sequence analysis
Eight microliter aliquots of PCR products were
separated electrophoretically on a 1.5% agarose gel stained
with ethidium bromide (EtBr) and visualized under UV
light. The amplified DNA was cloned into the pCR2.1
vector (Invitrogen, Carlsbad, CA), and the recombinant
vector transformed into Escherichia coli TOP10
(Invitrogen). Transformed E. coli TOP10 cells were then
plated onto Luria-Bertani (LB) agar plates containing
ampicillin (50 mg/ml) and incubated overnight at 37
oC.
Several clones were sequenced using the M13 forward and
the M13 reverse universal primers derived from the vector
sequence.
Results
Using ConA-stimulated canine PBMC cDNA as a
template, PCR amplification of cDNA was performed
using the BamHIcaIL3-F and HindIIIcaIL3-R primer pairI. cDNA cloning of canine IL-3 and IL-6 by PCR 117
to determine the whole sequence of canine IL-3. ConA
stimulation with an incubation time of 4h produced a more
sensitive PCR reaction than obtained with LPS or ConA
plus PMA stimulation with incubation times of 2h, 4h and
7h (data not shown). As expected from the design of the
primers BamHIcaIL3-F and HindIIIcaIL3-R, a single band
of approximately 480-bp was observed (Fig. 1, lane 2).
To determine the canine IL-6 protein coding sequence,
single stranded cDNA was made from total RNA of LPS-
stimulated PBMCs and amplified using the polymerase
chain reaction with il-6S and il-6R primers derived from
the sequences of canine IL-6 mRNA. Agarose gel
electrophoresis of the IL-6 PCR reaction products also
revealed a single band of about 620-bp, as expected (Fig.
1, lane 4).
Products obtained by PCR were purified and ligated
directly into pCR2.1 vector (Invitrogen) and the
nucleotides of each PCR product were sequenced in both
directions to determine their identities using M13 forward
and reverse universal primers derived from the vector
sequence.
The canine IL-3 PCR product of 480 bp that
encompassed the full coding region was also amplified.
The coding region of the canine IL-3 gene includes a
single open reading frame of 432 nucleotides, which
encodes a 143 amino acid polypeptide. Comparing
sequence homology at the nucleotide level with other
species in the coding region we obtained 67.1, 63.2, 56.3
and 37.7% in cow, sheep, human and rat, respectively. The
deduced amino acid sequence includes one possible N-
glycosylation site (Fig. 2, marked with a star). Canine IL-
3, like bovine and ovine IL-3, lacks the cystein residues
found in human and rat IL-3 proteins.
The determined nucleotide sequence for canine IL-6,
produced by PCR amplification, is shown in Fig. 3. It is
almost identical with the previously reported canine IL-6
Fig. 1. Electrophorectic analysis of canine IL-3 and IL-6 PCR
products with 1.5% agarose gel. 100 bp DNA ladder (lane 1), the
amplified 480-bp PCR product using PBMC-cDNA stimulated
ConA as a template with BamHIcaIL3-F and HindIIIcaIL3-R
primers (lane 2), 1kb DNA ladder (lane 3) and the 620-bp PCR
product using PBMC-cDNA stimulated LPS as a template with
il6S and il6R primers (lane 4).
Fig. 2. The nucleotide sequence and the predicted amino acid
sequence of canine IL-3. The deduced amino acid sequence is
shown by the single-letter amino acid code under the nucleotide
sequence and the stop codon is indicated by an asterisk (*). The
predicted amino acid terminus (Arg 24) of mature IL-3 is marked
with a triangle ( @). Potential N-glycosylation sites are marked
with stars ( è ).
Fig. 3. The nucleotide sequence and predicted amino acid
sequence of canine IL-6. The deduced amino acid sequence is
shown by the single-letter amino acid code under the nucleotide
sequence and the stop codon is indicated by an asterisk (*). The
positions at which the previously reported canine nucleic acid
and amino acid sequences (GeneBank accession number;
U12234) slightly differ from the sequences of PCR results are
indicated above and below the PCR sequences. This canine IL-6
cDNA sequence was deposited in the GeneBank nucleotide
database under accession number AF275796. The predicted
amino acid terminus (Phe 21) of mature IL-6 is marked with a
triangle (@).118  Il-Seob Shin et al.
mRNA (Genebank accession number; U12234) except for
two positions, a G at position 540 instead of a C residue
and a C at position 541 instead of G residue. The resulting
peptide has two substitutions of a Cys residue for Trp 180
and a Val residue for Leu 181, which suggests a higher
degree of homology than observed in other species. The
canine IL-6 cDNA sequence elucidated in this study was
deposited in the GeneBank nucleotide database under
accession number AF275796. An open reading frame
begins with the start codon ATG and ends at the stop codon
TAG, which is 621 bp long and has a 75, 84, 80, 74 and 58
% sequence homology with those of human [27], feline
[19], porcine [13], sheep [1] and rat [18] IL-6, respectively.
The deduced amino acid sequence does not include a
possible N-glycosylation site. It encodes a 20-amino acid
signal peptide followed by a 187-amino acid mature
protein (Fig. 3, triangle).
Discussion
We amplified the full coding region of canine IL-3 and
IL-6 from the blood cells of a dog by PCR. The canine IL-
3 open reading frame begins with an ATG start codon and
ends at a TGA stop codon. A computer-assisted alignment
of the canine, bovine, ovine, human and rat IL-3 amino
acid sequences (Fig. 4) revealed a low level of identity
among these species. IL-3 codes for a polypeptide of 143
amino acids, which is 1, 3, 9 and 23 amino acids shorter,
respectively, than the deduced bovine, ovine, human and
rat IL-3 sequences. Moreover, the nucleotide sequence
homology varied from 37% to 67% among these species
while at the amino acid level canine IL-3 shows identities
of 44.7%, 42.4%, 37% and 23.7%, with the cow, sheep,
human and rat IL-3 sequences. This inter-species
divergency made it difficult to amplify canine IL-3 cDNA
with primer pairs based on the sequences of the other
species.
The putative encoded protein consists of a leader peptide
of 23 amino acids, which is probably cleaved between the
glycine and arginine residues. Canine IL-3 signal peptide
shares 66.7% and 70.8% homology with bovine and ovine
IL-3, but less than 50% with human IL-3 and no significant
homology with rat IL-3. The mature protein has one
potential glycosylation site but previous studies have
shown that glycosylation dose not influence the role of the
mature protein [2]. The cysteine residues conserved in
human and rat IL-3 are absent in canine, bovine and ovine
protein but the predicted secondary structure of canine IL-
3 protein is a four alpha-helix topology, as is human
protein. Though inter-species comparison showed low
identity some of the residues are reported to play a critical
role in modulating the biological activity of the human
protein, such as proline, lysine and leucine, and these are
also conserved in the canine IL-3 protein [11,12].
A comparison of the amino acid sequences of IL-6 in
other species is shown in Fig. 5. The canine IL-6 cDNA
consists of an open reading frame of 207 amino acids, in
Fig. 4. The amino acid sequence of canine IL-3 gene was aligned
with those of cow, sheep, human and rat. Amino terminus of the
mature proteins ( @ ), potential N-glycosylation sites ( è ), and
conserved cysteine residues (0) are indicated. Dots indicate
identities with amino acids of the canine IL-3 sequence. Gaps
were introduced in sequences to maximize alignment (-). Those
amino acids reported to play a important role in regulating the
activity of human protein, together with the overlapping bovine,
ovine and canine residues are shown in bold. 
Fig. 5. The amino acid sequence of canine IL-6 gene was aligned
with those of its human, cat, pig, sheep and rat counterparts.
Amino terminus of the mature proteins ( @ ), potential N-
glycosylation sites (è), and conserved cysteine residues (0) are
indicated. Dots indicate identities with amino acids of the canine
IL-6 sequence. Gaps were introduced in sequences to maximize
alignment (-).I. cDNA cloning of canine IL-3 and IL-6 by PCR 119
which a putative 20-amino acid signal sequence precedes
Phe-21 at the amino terminus of the 187 amino acid
mature protein. The predicted amino acid sequence of
canine IL-6 shares 60.4, 77.2, 71.0, 55.8 and 42.0%
sequence identity with those of human, feline, porcine,
sheep and rat IL-6, respectively. IL-6 sequences are not
extensively conserved between species, but four cystein
residues forming disulfied bridges at positions 67-73 and
97-106 are well conserved.
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